|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratoire de Neurophysiologie Cellulaire et Intégrée, UMR 7519 CNRS/ULP, 21 rue R. Descartes, 67084 Strasbourg Cedex, France
Using whole cell voltage clamp recordings from lamina X neurones in rat spinal cord slices, we investigated the effect of glycine transporter (GlyT) antagonists on both glycinergic inhibitory postsynaptic current (IPSCs) and glutamatergic excitatory postsynaptic current (EPSCs). We used ORG 24598 and ORG 25543, selective antagonists of the glial GlyT (GlyT1) and neuronal GlyT (GlyT2), respectively. In rats (P12P16) and in the presence of kynurenic acid, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and bicuculline, ORG 24598 and ORG 25543 applied individually at a concentration of 10 µM induced a mean inward current of 10/50 pA at 60 mV and increased significantly the decay time constants of miniature (mIPSCs), spontaneous (sIPSCs) and electrically evoked glycinergic (eIPSCs) inhibitory postsynaptic currents. ORG 25543, but not ORG 24598, decreased the frequency of mIPSCs and sIPSCs. Replacing extracellular sodium with N-methyl-D-glucamine or superfusing the slice with micromolar concentrations of glycine also increased the decay time constant of glycinergic IPSCs. By contrast, the decay time constant, amplitude and frequency of miniature GABAergic IPSCs recorded in the presence of strychnine were not affected by ORG 24598 and ORG 25543. In the presence of strychnine, bicuculline and CNQX, we recorded electrically evoked NMDA receptor-mediated EPSCs (eEPSCs). eEPSCs were suppressed by 30 µMD-2-amino-5-phosphonovalerate (APV), an antagonist of the NMDA receptor, and by 30 µM dichlorokynurenic acid (DCKA), an antagonist of the glycine site of the NMDA receptor. Glycine (15 µM) and D-serine (10 µM) increased the amplitude of eEPSCs whereas L-serine had no effect. ORG 24598 and ORG 25543 increased significantly the amplitude of NMDA receptor-mediated eEPSCs without affecting the amplitude of non-NMDA receptor-mediated eEPSCs. We conclude that blocking glial and/or neuronal glycine transporters increased the level of glycine in spinal cord slices, which in turn prolonged the duration of glycinergic synaptic current and potentiated the NMDA-mediated synaptic response.
(Received 25 May 2004;
accepted after revision 22 June 2004;
first published online 2 July 2004)
Corresponding author J. Trouslard: Laboratoire de Neurophysiologie Cellulaire et Intégrée, UMR 7519 CNRS/ULP, 21 rue R. Descartes, 67084 Strasbourg Cedex, France. Email: trouslard{at}neurochem.u-strasbg.fr
This article has been cited by other articles:
![]() |
K. Morita, N. Motoyama, T. Kitayama, N. Morioka, K. Kifune, and T. Dohi Spinal Antiallodynia Action of Glycine Transporter Inhibitors in Neuropathic Pain Models in Mice J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 633 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beato The Time Course of Transmitter at Glycinergic Synapses onto Motoneurons J. Neurosci., July 16, 2008; 28(29): 7412 - 7425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Mitchell, L. J. Gentet, J. Dempster, and D. Belelli GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids J. Physiol., September 15, 2007; 583(3): 1021 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hejazi, C. Zhou, M. Oz, H. Sun, J. H. Ye, and L. Zhang {Delta}9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors Mol. Pharmacol., March 1, 2006; 69(3): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Aubrey, R. J. Vandenberg, and J. D. Clements Dynamics of Forward and Reverse Transport by the Glial Glycine Transporter, Glyt1b Biophys. J., September 1, 2005; 89(3): 1657 - 1668. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |